Search by Drug Name or NDC
NDC 71610-0229-30 LORAZEPAM 1 mg/1 Details
LORAZEPAM 1 mg/1
LORAZEPAM is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aphena Pharma Solutions - Tennessee, LLC. The primary component is LORAZEPAM.
MedlinePlus Drug Summary
Lorazepam is used to relieve anxiety. Lorazepam is in a class of medications called benzodiazepines. It works by slowing activity in the brain to allow for relaxation.
Related Packages: 71610-0229-30Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Lorazepam
Product Information
| NDC | 71610-0229 |
|---|---|
| Product ID | 71610-229_e2bf4a43-faf3-433b-8f77-8d5d03600845 |
| Associated GPIs | 57100060000310 |
| GCN Sequence Number | 003758 |
| GCN Sequence Number Description | lorazepam TABLET 1 MG ORAL |
| HIC3 | H20 |
| HIC3 Description | ANTI-ANXIETY - BENZODIAZEPINES |
| GCN | 14161 |
| HICL Sequence Number | 004846 |
| HICL Sequence Number Description | LORAZEPAM |
| Brand/Generic | Generic |
| Proprietary Name | LORAZEPAM |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | LORAZEPAM |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 1 |
| Active Ingredient Units | mg/1 |
| Substance Name | LORAZEPAM |
| Labeler Name | Aphena Pharma Solutions - Tennessee, LLC |
| Pharmaceutical Class | Benzodiazepine [EPC], Benzodiazepines [CS] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA203572 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 71610-0229-30 (71610022930)
| NDC Package Code | 71610-229-30 |
|---|---|
| Billing NDC | 71610022930 |
| Package | 30 TABLET in 1 BOTTLE (71610-229-30) |
| Marketing Start Date | 2019-02-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |